Xenon grants 17,850 inducement stock options, 10,500 RSUs to new hires under Nasdaq rule
XENE•Xenon Pharmaceuticals granted eight new non-officer employees 17,850 stock options and 10,500 restricted stock units (RSUs). The options are priced at $38.93 per share.
1. Award terms
The options are priced at $38.93 per share, matching the Oct. 1, 2026 closing price, and have a 10-year term. They vest over four years, with 25% vesting after one year and the remainder monthly. The RSUs vest in four equal annual installments, each on an anniversary of Oct. 1, 2026.
